Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


25.09.2017

2 Blood
2 Br J Haematol
1 Cancer
1 Haematologica
1 Int J Cancer
2 J Clin Oncol
2 Leuk Lymphoma
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood

  1. MALEK A, Bhagat G
    Cyclin D1-negative mantle cell lymphoma with aberrant CD3 expression.
    Blood. 2017;130:1388.
    PubMed     Text format    

  2. DING W, LaPlant BR, Call TG, Parikh SA, et al
    Pembrolizumab in patients with chronic lymphocytic leukemia with Richter's transformation and relapsed CLL.
    Blood. 2017 Apr 19. pii: blood-2017-02-765685. doi: 10.1182/blood-2017-02-765685
    PubMed     Text format     Abstract available


    Br J Haematol

  3. SROUR SA, Li S, Popat UR, Qazilbash MH, et al
    A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
    Br J Haematol. 2017;178:561-570.
    PubMed     Text format     Abstract available

  4. EYRE TA, Schuh A
    An update for Richter syndrome - new directions and developments.
    Br J Haematol. 2017;178:508-520.
    PubMed     Text format     Abstract available


    Cancer

  5. EHRHARDT MJ, Mulrooney DA, Li C, Baassiri MJ, et al
    Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
    Cancer. 2017 Sep 15. doi: 10.1002/cncr.31019.
    PubMed     Text format     Abstract available


    Haematologica

  6. EICHENAUER DA, Becker I, Monsef I, Chadwick N, et al
    Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials.
    Haematologica. 2017 Sep 14. pii: haematol.2017.167478.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    PubMed     Text format     Abstract available


    J Clin Oncol

  8. HERRERA AF, Armand P
    Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.
    J Clin Oncol. 2017 Sep 21:JCO2017745281. doi: 10.1200/JCO.2017.74.5281.
    PubMed     Text format     Abstract available

  9. SALZ T, Zabor EC, de Nully Brown P, Dalton SO, et al
    Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.
    J Clin Oncol. 2017 Sep 18:JCO2017724211. doi: 10.1200/JCO.2017.72.4211.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  10. MAZIARZ RT, Hao Y, Guerin A, Gauthier G, et al
    Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2017 Sep 21:1-10. doi: 10.1080/10428194.2017.1375100.
    PubMed     Text format     Abstract available

  11. HERTING F, Friess T, Umana P, Middleton S, et al
    Chemotherapy-free, triple combination of obinutuzumab, venetoclax and idasanutlin: antitumor activity in xenograft models of non-Hodgkin lymphoma.
    Leuk Lymphoma. 2017 Sep 15:1-4. doi: 10.1080/10428194.2017.1376740.
    PubMed     Text format    


    N Engl J Med

  12. RUSH RP, Saltman AP, Prica AA, Breiner A, et al
    Connecting the Dots.
    N Engl J Med. 2017;377:978-984.
    PubMed     Text format    


    PLoS One

  13. KOSMIDIS P, Bonzheim I, Dufke C, Colak S, et al
    Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.
    PLoS One. 2017;12:e0178503.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: